Replies to post #252541 on Biotech Values

[iwfal]

OPT - listened to “KOL conference call” and amusingly they said approximately same things i did:

A) 3 letters better is ‘meh’ (so focus with patients should be on higher percent people getting 15 letters etc)

B) intent is to pair their drug w whatever existing treatment is being used. (Reminder: all existing treatments use a loading dose (multiple months of monthly dosing)

Were i getting treatment i wld do exactly as being described by the KOLs. I.e. Get the OPT treatment with loading, then “treat and extend” per label of the non-OPT treatment. It might get a little tricky with very long lasting treatments like OCUL’s, but given the very unpleasant process of injections… .

Amusing note: one of the KOLs looks and sounds like George Clooney!